Taylor Frigon Capital Management LLC cut its position in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 8.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 23,789 shares of the company’s stock after selling 2,278 shares during the quarter. Astera Labs comprises 1.5% of Taylor Frigon Capital Management LLC’s portfolio, making the stock its 10th biggest position. Taylor Frigon Capital Management LLC’s holdings in Astera Labs were worth $2,607,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also modified their holdings of the company. Royal Bank of Canada raised its holdings in Astera Labs by 167.3% in the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after buying an additional 95,409 shares during the period. AQR Capital Management LLC increased its position in shares of Astera Labs by 213.4% in the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after acquiring an additional 7,756 shares in the last quarter. Empowered Funds LLC raised its stake in shares of Astera Labs by 917.3% in the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after acquiring an additional 4,183 shares during the period. First Trust Advisors LP boosted its position in Astera Labs by 102.0% during the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock worth $10,196,000 after purchasing an additional 56,952 shares during the period. Finally, Brown Advisory Inc. increased its holdings in Astera Labs by 54.9% in the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after purchasing an additional 1,977 shares in the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.
Astera Labs Trading Up 2.7%
ALAB stock opened at $393.16 on Thursday. The company has a market capitalization of $67.39 billion, a P/E ratio of 265.65, a PEG ratio of 4.39 and a beta of 3.66. The firm has a 50 day simple moving average of $326.75 and a 200-day simple moving average of $211.47. Astera Labs, Inc. has a twelve month low of $88.18 and a twelve month high of $499.48.
Insider Activity
In related news, Director Stefan A. Dyckerhoff sold 3,505 shares of the firm’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total transaction of $1,577,250.00. Following the transaction, the director directly owned 57,466 shares in the company, valued at $25,859,700. This trade represents a 5.75% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bethany Mayer sold 686 shares of the business’s stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $395.04, for a total transaction of $270,997.44. Following the sale, the director owned 5,550 shares of the company’s stock, valued at approximately $2,192,472. The trade was a 11.00% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 2,164,441 shares of company stock valued at $526,198,280 over the last three months. Company insiders own 10.40% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities research analysts have recently weighed in on ALAB shares. Barclays upped their target price on Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 7th. Morgan Stanley increased their price objective on shares of Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. UBS Group boosted their target price on shares of Astera Labs from $205.00 to $400.00 and gave the stock a “neutral” rating in a research report on Monday, June 29th. Weiss Ratings raised shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Finally, Stifel Nicolaus lifted their price target on shares of Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research note on Wednesday, June 24th. Twelve research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. Based on data from MarketBeat.com, Astera Labs currently has an average rating of “Moderate Buy” and a consensus target price of $265.75.
Read Our Latest Stock Analysis on ALAB
Astera Labs Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Recommended Stories
- Five stocks we like better than Astera Labs
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
